Recalls and suspensions

Subscribe to TGA safety information
14 September 2021
Recall due to risk of bacterial contamination
2 August 2021
Recall - Possible presence of benzene
3 June 2021
Product Defect Alert - child-resistant caps may not function correctly

More safety information »

Safety information

Subscribe to TGA safety information
14 October 2021
Information about the TGA's safety monitoring of COVID-19 vaccines.
14 October 2021
The TGA published an Actemra (tocilizumab) shortage - consumer information sheet produced by Pain Australia
11 October 2021
Safety advisory - Risk of pigmentary maculopathy (changes in the retina of the eye), especially after long-term use
11 October 2021
Health professionals are advised that the Product Information for pentosan polysulfate sodium has been updated with a warning about potential pigmentary maculopathy, especially after long-term use.

More safety information »

News

Subscribe to TGA latest news and updates
18 October 2021
The TGA has provisionally approved the use of the Roche Products Pty Ltd combination therapy, casirivimab + imdevimab (RONAPREVE), for the treatment and prevention of COVID-19 in specific target populations.
15 October 2021
A list of self-tests that are approved in Australia
15 October 2021
Australian prescription medicine decision summary
15 October 2021
This webinar will guide you through the new online form to request TGA approval to supply a medical device that is non-compliant with the EPs.

More news »